Germline mutations of the RET(10q11.2) have been reported in Hirschsprung's
disease (HSCR) at a rate of 15-45%. Recently, the glial cell line-derived
neurotrophic factor (GDNF) was identified as one of the ligands of the RET,
and GDNF (5p12-p13.1) mutations were also found in association with RET mu
tations in HSCR patients. We analysed the DNA sequence of RET and the GDNF
of patients with hypoganglionosis. We investigated the germline mutation in
5 patients histologically diagnosed with hypoganglionosis. DNAs were extra
cted from peripheral blood lymphocytes of these patients. The PCR primers w
ere designed for RET tyrosine kinase domain (exon 13-17) and GDNF (exon 1-2
). The DNA sequence was determined using a direct Dye-Deoxy Terminator Cycl
e method. The analysis of RET showed silent mutation at the codon 769 (CTT
--> CTG) by DNA polymorphism in all patients. No other mutation of the RET
or GDNF was evident. These results suggest that the RET or GDNF may not con
tribute to the pathogenesis of hypoganglionosis, which is suspected to be g
enetically different from HSCR.